The evolving dynamics of the microbial community in the cystic fibrosis lung

Environmental Microbiology

Volumn 17, Issue 1, 2015, Pages 16-28

  Mcguigan, Luke ^a   Callaghan, Máire ^a  

^a DUBLIN INSTITUTE OF TECHNOLOGY   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

PSEUDOMONAS AERUGINOSA;

ADAPTATION; ADULT; BACTERIAL INFECTION; BACTERIAL PHENOMENA AND FUNCTIONS; CHRONIC DISEASE; COMPLICATION; CYSTIC FIBROSIS; HUMAN; LUNG; MICROBIOLOGY; MICROFLORA; ORGANISMAL INTERACTION; PHYSIOLOGY; PSEUDOMONAS AERUGINOSA; QUORUM SENSING;

ADAPTATION, PHYSIOLOGICAL; ADULT; BACTERIAL INFECTIONS; BACTERIAL PHYSIOLOGICAL PHENOMENA; CHRONIC DISEASE; CYSTIC FIBROSIS; HUMANS; LUNG; MICROBIAL INTERACTIONS; MICROBIOTA; PSEUDOMONAS AERUGINOSA; QUORUM SENSING;

EID: 84921881930     PISSN: 14622912     EISSN: 14622920     Source Type: Journal    
DOI: 10.1111/1462-2920.12504     Document Type: Short Survey

References (129)

1. Al-Khodor, S., Marshall-Batty, K., Nair, V., Ding, L., Greenberg, D.E., and Fraser, I.D. (2014) Burkholderia cenocepacia J2315 escapes to the cytosol and actively subverts autophagy in human macrophages. Cell Microbiol 16: 378-395.
2. Amiel, E., Lovewell, R.R., O'Toole, G.A., Hogan, D.A., and Berwin, B. (2010) Pseudomonas aeruginosa evasion of phagocytosis is mediated by loss of swimming motility and is independent of flagellum expression. Infect Immun 78: 2937-2945.
3. Amin, R., and Waters, V. (2012) Antibiotic treatment for Stenotrophomonas maltophilia in people with cystic fibrosis. Cochrane Database Syst Rev 5: 1-14.
4. Amin, R., Dupuis, A., Aaron, S.D., and Ratjen, F. (2010) The effect of chronic infection with Aspergillus fumigatus on lung function and hospitalization in patients with cystic fibrosis. Chest 137: 171-176.
5. Andersen, D.H. (1938) Cystic fibrosis of the pancreas and its relation to celiac disease: a clinical and pathologic study. Am J Dis Child 56: 344-399.
6. Asner, S., Waters, V., Solomon, M., Yau, Y., Richardson, S.E., Grasemann, H., etal. (2012) Role of respiratory viruses in pulmonary exacerbations in children with cystic fibrosis. J Cyst Fibros 11: 433-439.
7. Bakkal, S., Robinson, S.M., Ordonez, C.L., Waltz, D.A., and Riley, M.A. (2010) Role of bacteriocins in mediating interactions of bacterial isolates taken from cystic fibrosis patients. Microbiology 156: 2058-2067.
8. Baldwin, A., Sokol, P.A., Parkhill, J., and Mahenthiralingam, E. (2004) The Burkholderia cepacia epidemic strain marker is part of a novel genomic island encoding both virulence and metabolism-associated genes in Burkholderia cenocepacia. Infect Immun 72: 1537-1547.
9. Baldwin, A., Mahenthiralingam, E., Drevinek, P., Vandamme, P., Govan, J.R., Waine, D.J., etal. (2007) Environmental Burkholderia cepacia complex isolates in human infections. Emerg Infect Dis 13: 458-461.
10. Bjarnsholt, T., Jensen, P.O., Jakobsen, T.H., Phipps, R., Nielsen, A.K., Rybtke, M.T., etal. (2010) Quorum sensing and virulence of Pseudomonas aeruginosa during lung infection of cystic fibrosis patients. PLoS ONE 5: 1-10.
11. Blainey, P.C., Milla, C.E., Cornfield, D.N., and Quake, S.R. (2012) Quantitative analysis of the human airway microbial ecology reveals a pervasive signature for cystic fibrosis. Sci Transl Med 4: 1-22.
12. Boon, C., Deng, Y., Wang, L.H., He, Y., Xu, J.L., Fan, Y., etal. (2008) A novel DSF-like signal from Burkholderia cenocepacia interferes with Candida albicans morphological transition. Isme j 2: 27-36.
13. Bragonzi, A., Paroni, M., Nonis, A., Cramer, N., Montanari, S., Rejman, J., etal. (2009) Pseudomonas aeruginosa microevolution during cystic fibrosis lung infection establishes clones with adapted virulence. Am J Respir Crit Care Med 180: 138-145.
14. Bragonzi, A., Farulla, I., Paroni, M., Twomey, K.B., Pirone, L., Lore, N.I., etal. (2012) Modelling co-infection of the cystic fibrosis lung by Pseudomonas aeruginosa and Burkholderia cenocepacia reveals influences on biofilm formation and host response. PLoS ONE 7: 1-12.
15. Butterworth, M.B., Zhang, L., Heidrich, E.M., Myerburg, M.M., and Thibodeau, P.H. (2012) Activation of the epithelial sodium channel (ENaC) by the alkaline protease from Pseudomonas aeruginosa. J Biol Chem 287: 32556-32565.
16. Callaghan, M., and McClean, S. (2012) Bacterial host interactions in cystic fibrosis. Curr Opin Microbiol 15: 71-77.
17. Caraher, E., Collins, J., Herbert, G., Murphy, P.G., Gallagher, C.G., Crowe, M.J., etal. (2008) Evaluation of in vitro virulence characteristics of the genus Pandoraea in lung epithelial cells. J Med Microbiol 57: 15-20.
18. Carnes, E.C., Lopez, D.M., Donegan, N.P., Cheung, A., Gresham, H., Timmins, G.S., and Brinker, C.J. (2010) Confinement-induced quorum sensing of individual Staphylococcus aureus bacteria. Nat Chem Biol 6: 41-45.
19. Chambers, C.E., Visser, M.B., Schwab, U., and Sokol, P.A. (2005) Identification of N-acylhomoserine lactones in mucopurulent respiratory secretions from cystic fibrosis patients. FEMS Microbiol Lett 244: 297-304.
20. Chattoraj, S.S., Murthy, R., Ganesan, S., Goldberg, J.B., Zhao, Y., Hershenson, M.B., and Sajjan, U.S. (2010) Pseudomonas aeruginosa alginate promotes Burkholderia cenocepacia persistence in cystic fibrosis transmembrane conductance regulator knockout mice. Infect Immun 78: 984-993.
21. Claesson, M.J., Wang, Q., O'Sullivan, O., Greene-Diniz, R., Cole, J.R., Ross, R.P., and O'Toole, P.W. (2010) Comparison of two next-generation sequencing technologies for resolving highly complex microbiota composition using tandem variable 16S rRNA gene regions. Nucleic Acids Res 38: 1-13.
22. Colomb, F., Vidal, O., Bobowski, M., Krzewinski-Recchi, M.A., Harduin-Lepers, A., Mensier, E., etal. (2013) TNF induces the expression of the sialyltransferase ST3Gal IV in human bronchial mucosa via MSK1/2 protein kinases and increases FliD/sialyl-Lewisx mediated adhesion of Pseudomonas aeruginosa. Biochem J 457: 79-87.
23. Connell, J.L., Ritschdorff, E.T., Whiteley, M., and Shear, J.B. (2013) 3D printing of microscopic bacterial communities. Proc Natl Acad Sci USA 110: 18380-18385.
24. Conway, B.A., and Greenberg, E.P. (2002) Quorum-sensing signals and quorum-sensing genes in Burkholderia vietnamiensis. J Bacteriol 184: 1187-1191.
25. Costello, A., Herbert, G., Fabunmi, L., Schaffer, K., Kavanagh, K.A., Caraher, E.M., etal. (2011) Virulence of an emerging respiratory pathogen, genus Pandoraea, in vivo and its interactions with lung epithelial cells. J Med Microbiol 60: 289-299.
26. Coutinho, C.P., de Carvalho, C.C., Madeira, A., Pinto-de-Oliveira, A., and Sa-Correia, I. (2011) Burkholderia cenocepacia phenotypic clonal variation during a 3.5-year colonization in the lungs of a cystic fibrosis patient. Infect Immun 79: 2950-2960.
27. Cox, M.J., Allgaier, M., Taylor, B., Baek, M.S., Huang, Y.J., Daly, R.A., etal. (2010) Airway microbiota and pathogen abundance in age-stratified cystic fibrosis patients. PLoS ONE 5: 1-10.
28. Cugini, C., Calfee, M.W., Farrow, J.M., 3rd, Morales, D.K., Pesci, E.C., and Hogan, D.A. (2007) Farnesol, a common sesquiterpene, inhibits PQS production in Pseudomonas aeruginosa. Mol Microbiol 65: 896-906.
29. Dalboge, C.S., Hansen, C.R., Pressler, T., Hoiby, N., and Johansen, H.K. (2011) Chronic pulmonary infection with Stenotrophomonas maltophilia and lung function in patients with cystic fibrosis. J Cyst Fibros 10: 318-325.
30. D'Argenio, D.A., Wu, M., Hoffman, L.R., Kulasekara, H.D., Deziel, E., Smith, E.E., etal. (2007) Growth phenotypes of Pseudomonas aeruginosa lasR mutants adapted to the airways of cystic fibrosis patients. Mol Microbiol 64: 512-533.
31. De Soyza, A., Ellis, C.D., Khan, C.M., Corris, P.A., and Demarco de Hormaeche, R. (2004) Burkholderia cenocepacia lipopolysaccharide, lipid A, and proinflammatory activity. Am J Respir Crit Care Med 170: 70-77.
32. Delhaes, L., Monchy, S., Frealle, E., Hubans, C., Salleron, J., Leroy, S., etal. (2012) The airway microbiota in cystic fibrosis: a complex fungal and bacterial community - implications for therapeutic management. PLoS ONE 7: 1-14.
33. Denman, C.C., Robinson, M.T., Sass, A.M., Mahenthiralingam, E., and Brown, A.R. (2013) Growth on mannitol-rich media elicits a genome-wide transcriptional response in Burkholderia multivorans that impacts on multiple virulence traits in an exopolysaccharide-independent manner. Microbiology 160: 187-197.
34. Di Lorenzo, F., Silipo, A., Costello, A., Sturiale, L., Garozzo, D., Callaghan, M., etal. (2012) Structural study of the lipopolysaccharide o-antigen produced by the emerging cystic fibrosis pathogen Pandoraea pulmonicola. Eur J Org Chem 2012: 2243-2249.
35. Duff, C., Murphy, P.G., Callaghan, M., and McClean, S. (2006) Differences in invasion and translocation of Burkholderia cepacia complex species in polarised lung epithelial cells in vitro. Microb Pathog 41: 183-192.
36. El-Halfawy, O.M., and Valvano, M.A. (2013) Chemical communication of antibiotic resistance by a highly resistant subpopulation of bacterial cells. PLoS ONE 8: 1-10.
37. Feldman, M., Bryan, R., Rajan, S., Scheffler, L., Brunnert, S., Tang, H., and Prince, A. (1998) Role of flagella in pathogenesis of Pseudomonas aeruginosa pulmonary infection. Infect Immun 66: 43-51.
38. Fernandez, L., Alvarez-Ortega, C., Wiegand, I., Olivares, J., Kocincova, D., Lam, J.S., etal. (2013) Characterization of the polymyxin B resistome of Pseudomonas aeruginosa. Antimicrob Agents Chemother 57: 110-119.
39. Flannagan, R.S., and Valvano, M.A. (2008) Burkholderia cenocepacia requires RpoE for growth under stress conditions and delay of phagolysosomal fusion in macrophages. Microbiology 154: 643-653.
40. Flickinger, S.T., Copeland, M.F., Downes, E.M., Braasch, A.T., Tuson, H.H., Eun, Y.J., and Weibel, D.B. (2011) Quorum sensing between Pseudomonas aeruginosa biofilms accelerates cell growth. J Am Chem Soc 133: 5966-5975.
41. Fodor, A.A., Klem, E.R., Gilpin, D.F., Elborn, J.S., Boucher, R.C., Tunney, M.M., and Wolfgang, M.C. (2012) The adult cystic fibrosis airway microbiota is stable over time and infection type, and highly resilient to antibiotic treatment of exacerbations. PLoS ONE 7: 1-15.
42. Ghequire, M.G., De Canck, E., Wattiau, P., Van Winge, I., Loris, R., Coenye, T., and De Mot, R. (2013) Antibacterial activity of a lectin-like Burkholderia cenocepacia protein. Microbiologyopen 2: 566-575.
43. Gotschlich, A., Huber, B., Geisenberger, O., Togl, A., Steidle, A., Riedel, K., etal. (2001) Synthesis of multiple N-acylhomoserine lactones is wide-spread among the members of the Burkholderia cepacia complex. Syst Appl Microbiol 24: 1-14.
44. Guo, Q., Kong, W., Jin, S., Chen, L., Xu, Y., and Duan, K. (2013) PqsR-dependent and PqsR-independent regulation of motility and biofilm formation by PQS in Pseudomonas aeruginosa PAO1. J Basic Microbiol 53: 1-11.
45. Guss, A.M., Roeselers, G., Newton, I.L., Young, C.R., Klepac-Ceraj, V., Lory, S., and Cavanaugh, C.M. (2011) Phylogenetic and metabolic diversity of bacteria associated with cystic fibrosis. Isme j 5: 20-29.
46. Haley, K.P., and Skaar, E.P. (2012) A battle for iron: host sequestration and Staphylococcus aureus acquisition. Microbes Infect 14: 217-227.
47. Hammer, N.D., and Skaar, E.P. (2011) Molecular mechanisms of Staphylococcus aureus iron acquisition. Annu Rev Microbiol 65: 129-147.
48. Harrison, F., Paul, J., Massey, R.C., and Buckling, A. (2008) Interspecific competition and siderophore-mediated cooperation in Pseudomonas aeruginosa. Isme j 2: 49-55.
49. Heimer, S.R., Evans, D.J., Stern, M.E., Barbieri, J.T., Yahr, T., and Fleiszig, S.M. (2013) Pseudomonas aeruginosa utilizes the type III secreted toxin exos to avoid acidified compartments within epithelial cells. PLoS ONE 8: 1-13.
50. Hirschhausen, N., Block, D., Bianconi, I., Bragonzi, A., Birtel, J., Lee, J.C., etal. (2013) Extended Staphylococcus aureus persistence in cystic fibrosis is associated with bacterial adaptation. Int J Med Microbiol 303: 685-692.
51. Hoboth, C., Hoffmann, R., Eichner, A., Henke, C., Schmoldt, S., Imhof, A., etal. (2009) Dynamics of adaptive microevolution of hypermutable Pseudomonas aeruginosa during chronic pulmonary infection in patients with cystic fibrosis. J Infect Dis 200: 118-130.
52. Hoffman, L.R., Deziel, E., D'Argenio, D.A., Lepine, F., Emerson, J., McNamara, S., etal. (2006) Selection for Staphylococcus aureus small-colony variants due to growth in the presence of Pseudomonas aeruginosa. Proc Natl Acad Sci USA 103: 19890-19895.
53. Hogan, D.A., and Kolter, R. (2002) Pseudomonas-Candida interactions: an ecological role for virulence factors. Science 296: 2229-2232.
54. Hogan, D.A., Vik, A., and Kolter, R. (2004) A Pseudomonas aeruginosa quorum-sensing molecule influences Candida albicans morphology. Mol Microbiol 54: 1212-1223.
55. Hosono Honda, N., Kimura, S., Tateda, K., Horikawa, M., Ueda, C., Ishii, Y., etal. (2011) Roles of Pseudomonas aeruginosa autoinducers and their degradation products, tetramic acids, in bacterial survival and behavior in ecological niches. Microbes Environ 26: 160-164.
56. Hubert, D., Reglier-Poupet, H., Sermet-Gaudelus, I., Ferroni, A., Le Bourgeois, M., Burgel, P.R., etal. (2013) Association between Staphylococcus aureus alone or combined with Pseudomonas aeruginosa and the clinical condition of patients with cystic fibrosis. J Cyst Fibros 12: 497-503.
57. Huse, H.K., Kwon, T., Zlosnik, J.E., Speert, D.P., Marcotte, E.M., and Whiteley, M. (2013) Pseudomonas aeruginosa enhances production of a non-alginate exopolysaccharide during long-term colonization of the cystic fibrosis lung. PLoS ONE 8: 1-8.
58. Huynh, K.K., Plumb, J.D., Downey, G.P., Valvano, M.A., and Grinstein, S. (2010) Inactivation of macrophage Rab7 by Burkholderia cenocepacia. J Innate Immun 2: 522-533.
59. Jorgensen, I.M., Johansen, H.K., Frederiksen, B., Pressler, T., Hansen, A., Vandamme, P., etal. (2003) Epidemic spread of Pandoraea apista, a new pathogen causing severe lung disease in cystic fibrosis patients. Pediatr Pulmonol 36: 439-446.
60. Kalish, L.A., Waltz, D.A., Dovey, M., Potter-Bynoe, G., McAdam, A.J., Lipuma, J.J., etal. (2006) Impact of Burkholderia dolosa on lung function and survival in cystic fibrosis. Am J Respir Crit Care Med 173: 421-425.
61. Kaza, S.K., McClean, S., and Callaghan, M. (2011) IL-8 released from human lung epithelial cells induced by cystic fibrosis pathogens Burkholderia cepacia complex affects the growth and intracellular survival of bacteria. Int J Med Microbiol 301: 26-33.
62. Keith, K.E., Hynes, D.W., Sholdice, J.E., and Valvano, M.A. (2009) Delayed association of the NADPH oxidase complex with macrophage vacuoles containing the opportunistic pathogen Burkholderia cenocepacia. Microbiology 155: 1004-1015.
63. Kelly, C., Canning, P., Buchanan, P.J., Williams, M.T., Brown, V., Gruenert, D.C., etal. (2013) Toll-like receptor 4 is not targeted to the lysosome in cystic fibrosis airway epithelial cells. Am J Physiol Lung Cell Mol Physiol 304: 371-382.
64. Kieninger, E., Singer, F., Tapparel, C., Alves, M.P., Latzin, P., Tan, H.L., etal. (2013) High rhinovirus burden in lower airways of children with cystic fibrosis. Chest 143: 782-790.
65. Kim, J.Y., Sajjan, U.S., Krasan, G.P., and LiPuma, J.J. (2005) Disruption of tight junctions during traversal of the respiratory epithelium by Burkholderia cenocepacia. Infect Immun 73: 7107-7112.
66. Klepac-Ceraj, V., Lemon, K.P., Martin, T.R., Allgaier, M., Kembel, S.W., Knapp, A.A., etal. (2010) Relationship between cystic fibrosis respiratory tract bacterial communities and age, genotype, antibiotics and Pseudomonas aeruginosa. Environ Microbiol 12: 1293-1303.
67. Konings, A.F., Martin, L.W., Sharples, K.J., Roddam, L.F., Latham, R., Reid, D.W., and Lamont, I.L. (2013) Pseudomonas aeruginosa uses multiple pathways to acquire iron during chronic infection in cystic fibrosis lungs. Infect Immun 81: 2697-2704.
68. Kotrange, S., Kopp, B., Akhter, A., Abdelaziz, D., Abu Khweek, A., Caution, K., etal. (2011) Burkholderia cenocepacia O polysaccharide chain contributes to caspase-1-dependent IL-1beta production in macrophages. J Leukoc Biol 89: 481-488.
69. Lambiase, A., Catania, M.R., and Rossano, F. (2010) Anaerobic bacteria infection in cystic fibrosis airway disease. New Microbiol 33: 185-194.
70. Lee, B., Schjerling, C.K., Kirkby, N., Hoffmann, N., Borup, R., Molin, S., etal. (2011) Mucoid Pseudomonas aeruginosa isolates maintain the biofilm formation capacity and the gene expression profiles during the chronic lung infection of CF patients. APMIS 119: 263-274.
71. LiPuma, J.J., Spilker, T., Coenye, T., and Gonzalez, C.F. (2002) An epidemic Burkholderia cepacia complex strain identified in soil. Lancet 359: 2002-2003.
72. Lopes, S.P., Ceri, H., Azevedo, N.F., and Pereira, M.O. (2012) Antibiotic resistance of mixed biofilms in cystic fibrosis: impact of emerging microorganisms on treatment of infection. Int J Antimicrob Agents 40: 260-263.
73. Lore, N.I., Cigana, C., De Fino, I., Riva, C., Juhas, M., Schwager, S., etal. (2012) Cystic fibrosis-niche adaptation of Pseudomonas aeruginosa reduces virulence in multiple infection hosts. PLoS ONE 7: 1-9.
74. Lory, S., Merighi, M., and Hyodo, M. (2009) Multiple activities of c-di-GMP in Pseudomonas aeruginosa. Nucleic Acids Symp Ser (Oxf) 53: 51-52.
75. Lowery, C.A., Park, J., Gloeckner, C., Meijler, M.M., Mueller, R.S., Boshoff, H.I., etal. (2009) Defining the mode of action of tetramic acid antibacterials derived from Pseudomonas aeruginosa quorum sensing signals. J Am Chem Soc 131: 14473-14479.
76. McClean, S., and Callaghan, M. (2009) Burkholderia cepacia complex: epithelial cell-pathogen confrontations and potential for therapeutic intervention. J Med Microbiol 58: 1-12.
77. McKenney, D., Brown, K.E., and Allison, D.G. (1995) Influence of Pseudomonas aeruginosa exoproducts on virulence factor production in Burkholderia cepacia: evidence of interspecies communication. J Bacteriol 177: 6989-6992.
78. McKeon, S.A., Nguyen, D.T., Viteri, D.F., Zlosnik, J.E., and Sokol, P.A. (2011) Functional quorum sensing systems are maintained during chronic Burkholderia cepacia complex infections in patients with cystic fibrosis. J Infect Dis 203: 383-392.
79. Madeira, A., Santos, P.M., Coutinho, C.P., Pinto-de-Oliveira, A., and Sa-Correia, I. (2011) Quantitative proteomics (2-D DIGE) reveals molecular strategies employed by Burkholderia cenocepacia to adapt to the airways of cystic fibrosis patients under antimicrobial therapy. Proteomics 11: 1313-1328.
80. Madeira, A., Dos Santos, S.C., Santos, P.M., Coutinho, C.P., Tyrrell, J., McClean, S., etal. (2013) Proteomic profiling of Burkholderia cenocepacia clonal isolates with different virulence potential retrieved from a cystic fibrosis patient during chronic lung infection. PLoS ONE 8: 1-14.
81. Middleton, B., Rodgers, H.C., Camara, M., Knox, A.J., Williams, P., and Hardman, A. (2002) Direct detection of N-acylhomoserine lactones in cystic fibrosis sputum. FEMS Microbiol Lett 207: 1-7.
82. Mira, N.P., Madeira, A., Moreira, A.S., Coutinho, C.P., and Sa-Correia, I. (2011) Genomic expression analysis reveals strategies of Burkholderia cenocepacia to adapt to cystic fibrosis patients' airways and antimicrobial therapy. PLoS ONE 6: 1-14.
83. Moree, W.J., Phelan, V.V., Wu, C.H., Bandeira, N., Cornett, D.S., Duggan, B.M., and Dorrestein, P.C. (2012) Interkingdom metabolic transformations captured by microbial imaging mass spectrometry. Proc Natl Acad Sci USA 109: 13811-13816.
84. Moskowitz, S.M., Ernst, R.K., and Miller, S.I. (2004) PmrAB, a two-component regulatory system of Pseudomonas aeruginosa that modulates resistance to cationic antimicrobial peptides and addition of aminoarabinose to lipid A. J Bacteriol 186: 575-579.
85. Mossialos, D., and Amoutzias, G.D. (2009) Role of siderophores in cystic fibrosis pathogenesis: foes or friends? Int J Med Microbiol 299: 87-98.
86. Mowat, E., Rajendran, R., Williams, C., McCulloch, E., Jones, B., Lang, S., and Ramage, G. (2010) Pseudomonas aeruginosa and their small diffusible extracellular molecules inhibit Aspergillus fumigatus biofilm formation. FEMS Microbiol Lett 313: 96-102.
87. Muir, A., Soong, G., Sokol, S., Reddy, B., Gomez, M.I., Van Heeckeren, A., and Prince, A. (2004) Toll-like receptors in normal and cystic fibrosis airway epithelial cells. Am J Respir Cell Mol Biol 30: 777-783.
88. Mullen, T., Callaghan, M., and McClean, S. (2010) Invasion of Burkholderia cepacia complex isolates into lung epithelial cells involves glycolipid receptors. Microb Pathog 49: 381-387.
89. Muller, C., Plesiat, P., and Jeannot, K. (2011) A two-component regulatory system interconnects resistance to polymyxins, aminoglycosides, fluoroquinolones, and beta-lactams in Pseudomonas aeruginosa. Antimicrob Agents Chemother 55: 1211-1221.
90. Oliver, A., Canton, R., Campo, P., Baquero, F., and Blazquez, J. (2000) High frequency of hypermutable Pseudomonas aeruginosa in cystic fibrosis lung infection. Science 288: 1251-1254.
91. Ong, T., and Ramsey, B.W. (2013) Modifying disease in cystic fibrosis: current and future therapies on the horizon. Curr Opin Pulm Med 19: 645-651.
92. O'Reilly, R., and Elphick, H.E. (2013) Development, clinical utility, and place of ivacaftor in the treatment of cystic fibrosis. Drug Des Devel Ther 7: 929-937.
93. Patankar, Y.R., Lovewell, R.R., Poynter, M.E., Jyot, J., Kazmierczak, B.I., and Berwin, B. (2013) Flagellar motility is a key determinant of the magnitude of the inflammasome response to Pseudomonas aeruginosa. Infect Immun 81: 2043-2052.
94. Peeters, C., Zlosnik, J.E., Spilker, T., Hird, T.J., LiPuma, J.J., and Vandamme, P. (2013) Burkholderia pseudomultivorans sp. nov., a novel Burkholderia cepacia complex species from human respiratory samples and the rhizosphere. Syst Appl Microbiol 36: 483-489.
95. Pessi, G., Braunwalder, R., Grunau, A., Omasits, U., Ahrens, C.H., and Eberl, L. (2013) Response of Burkholderia cenocepacia H111 to micro-oxia. PLoS ONE 8: 1-13.
96. Pillarisetti, N., Williamson, E., Linnane, B., Skoric, B., Robertson, C.F., Robinson, P., etal. (2011) Infection, inflammation, and lung function decline in infants with cystic fibrosis. Am J Respir Crit Care Med 184: 75-81.
97. Popat, R., Crusz, S.A., Messina, M., Williams, P., West, S.A., and Diggle, S.P. (2012) Quorum-sensing and cheating in bacterial biofilms. Proc Biol Sci 279: 4765-4771.
98. Qin, X., Zerr, D.M., McNutt, M.A., Berry, J.E., Burns, J.L., and Kapur, R.P. (2012) Pseudomonas aeruginosa syntrophy in chronically colonized airways of cystic fibrosis patients. Antimicrob Agents Chemother 56: 5971-5981.
99. Ramirez, I.A., Caverly, L.L., Kalikin, L.M., Goldsmith, A.M., Lewis, T.C., Burke, D.T., etal. (2014) Differential responses to rhinovirus and influenza-associated pulmonary exacerbations in patients with cystic fibrosis. Ann Am Thorac Soc 11: 554-561.
100. Sajjan, S.U., Carmody, L.A., Gonzalez, C.F., and LiPuma, J.J. (2008) A type IV secretion system contributes to intracellular survival and replication of Burkholderia cenocepacia. Infect Immun 76: 5447-5455.
101. Sass, A.M., Schmerk, C., Agnoli, K., Norville, P.J., Eberl, L., Valvano, M.A., and Mahenthiralingam, E. (2013) The unexpected discovery of a novel low-oxygen-activated locus for the anoxic persistence of Burkholderia cenocepacia. Isme j 7: 1568-1581.
102. Schmerk, C.L., and Valvano, M.A. (2013) Burkholderia multivorans survival and trafficking within macrophages. J Med Microbiol 62: 173-184.
103. Sibley, C.D., Parkins, M.D., Rabin, H.R., Duan, K., Norgaard, J.C., and Surette, M.G. (2008a) A polymicrobial perspective of pulmonary infections exposes an enigmatic pathogen in cystic fibrosis patients. Proc Natl Acad Sci USA 105: 15070-15075.
104. Sibley, C.D., Duan, K., Fischer, C., Parkins, M.D., Storey, D.G., Rabin, H.R., and Surette, M.G. (2008b) Discerning the complexity of community interactions using a Drosophila model of polymicrobial infections. PLoS Pathog 4: 1-10.
105. Silva, I.N., Ferreira, A.S., Becker, J.D., Zlosnik, J.E., Speert, D.P., He, J., etal. (2011) Mucoid morphotype variation of Burkholderia multivorans during chronic cystic fibrosis lung infection is correlated with changes in metabolism, motility, biofilm formation and virulence. Microbiology 157: 3124-3137.
106. Smith, K., Martin, L., Rinaldi, A., Rajendran, R., Ramage, G., and Walker, D. (2012) Activity of pyocin S2 against Pseudomonas aeruginosa biofilms. Antimicrob Agents Chemother 56: 1599-1601.
107. Sousa, S.A., Ramos, C.G., and Leitao, J.H. (2011) Burkholderia cepacia complex: emerging multihost pathogens equipped with a wide range of virulence factors and determinants. Int J Microbiol 2011: 1-9.
108. Speirs, J.J., van der Ent, C.K., and Beekman, J.M. (2012) Effects of Aspergillus fumigatus colonization on lung function in cystic fibrosis. Curr Opin Pulm Med 18: 632-638.
109. Struss, A.K., Nunes, A., Waalen, J., Lowery, C.A., Pullanikat, P., Denery, J.R., etal. (2013) Toward implementation of quorum sensing autoinducers as biomarkers for infectious disease states. Anal Chem 85: 3355-3362.
110. Tashiro, Y., Yawata, Y., Toyofuku, M., Uchiyama, H., and Nomura, N. (2013) Interspecies interaction between Pseudomonas aeruginosa and other microorganisms. Microbes Environ 28: 13-24.
111. Traverse, C.C., Mayo-Smith, L.M., Poltak, S.R., and Cooper, V.S. (2013) Tangled bank of experimentally evolved Burkholderia biofilms reflects selection during chronic infections. Proc Natl Acad Sci USA 110: 250-259.
112. Tuchscherr, L., Medina, E., Hussain, M., Volker, W., Heitmann, V., Niemann, S., etal. (2011) Staphylococcus aureus phenotype switching: an effective bacterial strategy to escape host immune response and establish a chronic infection. EMBO Mol Med 3: 129-141.
113. Tunney, M.M., Field, T.R., Moriarty, T.F., Patrick, S., Doering, G., Muhlebach, M.S., etal. (2008) Detection of anaerobic bacteria in high numbers in sputum from patients with cystic fibrosis. Am J Respir Crit Care Med 177: 995-1001.
114. Twomey, K.B., O'Connell, O.J., McCarthy, Y., Dow, J.M., O'Toole, G.A., Plant, B.J., and Ryan, R.P. (2012) Bacterial cis-2-unsaturated fatty acids found in the cystic fibrosis airway modulate virulence and persistence of Pseudomonas aeruginosa. Isme j 6: 939-950.
115. Ulrich, M., Beer, I., Braitmaier, P., Dierkes, M., Kummer, F., Krismer, B., etal. (2010) Relative contribution of Prevotella intermedia and Pseudomonas aeruginosa to lung pathology in airways of patients with cystic fibrosis. Thorax 65: 978-984.
116. Van Ewijk, B.E., Wolfs, T.F., Aerts, P.C., Van Kessel, K.P., Fleer, A., Kimpen, J.L., and van der Ent, C.K. (2007) RSV mediates Pseudomonas aeruginosa binding to cystic fibrosis and normal epithelial cells. Pediatr Res 61: 398-403.
117. Vanlaere, E., Lipuma, J.J., Baldwin, A., Henry, D., De Brandt, E., Mahenthiralingam, E., etal. (2008) Burkholderia latens sp. nov., Burkholderia diffusa sp. nov., Burkholderia arboris sp. nov., Burkholderia seminalis sp. nov. and Burkholderia metallica sp. nov., novel species within the Burkholderia cepacia complex. Int J Syst Evol Microbiol 58: 1580-1590.
118. Vanlaere, E., Baldwin, A., Gevers, D., Henry, D., De Brandt, E., LiPuma, J.J., etal. (2009) Taxon K, a complex within the Burkholderia cepacia complex, comprises at least two novel species, Burkholderia contaminans sp. nov. and Burkholderia lata sp. nov. Int J Syst Evol Microbiol 59: 102-111.
119. Vial, L., Chapalain, A., Groleau, M.C., and Deziel, E. (2011) The various lifestyles of the Burkholderia cepacia complex species: a tribute to adaptation. Environ Microbiol 13: 1-12.
120. Waite, R.D., and Curtis, M.A. (2009) Pseudomonas aeruginosa PAO1 pyocin production affects population dynamics within mixed-culture biofilms. J Bacteriol 191: 1349-1354.
121. Winstanley, C., and Fothergill, J.L. (2009) The role of quorum sensing in chronic cystic fibrosis Pseudomonas aeruginosa infections. FEMS Microbiol Lett 290: 1-9.
122. Wolter, D.J., Emerson, J.C., McNamara, S., Buccat, A.M., Qin, X., Cochrane, E., etal. (2013) Staphylococcus aureus small-colony variants are independently associated with worse lung disease in children with cystic fibrosis. Clin Infect Dis 57: 384-391.
123. Woo, J.K., Webb, J.S., Kirov, S.M., Kjelleberg, S., and Rice, S.A. (2012) Biofilm dispersal cells of a cystic fibrosis Pseudomonas aeruginosa isolate exhibit variability in functional traits likely to contribute to persistent infection. FEMS Immunol Med Microbiol 66: 251-264.
124. Workentine, M.L., Sibley, C.D., Glezerson, B., Purighalla, S., Norgaard-Gron, J.C., Parkins, M.D., etal. (2013) Phenotypic heterogeneity of Pseudomonas aeruginosa populations in a cystic fibrosis patient. PLoS ONE 8: 1-10.
125. Yang, L., Liu, Y., Markussen, T., Hoiby, N., Tolker-Nielsen, T., and Molin, S. (2011) Pattern differentiation in co-culture biofilms formed by Staphylococcus aureus and Pseudomonas aeruginosa. FEMS Immunol Med Microbiol 62: 339-347.
126. Zhao, J., Schloss, P.D., Kalikin, L.M., Carmody, L.A., Foster, B.K., Petrosino, J.F., etal. (2012) Decade-long bacterial community dynamics in cystic fibrosis airways. Proc Natl Acad Sci USA 109: 5809-5814.
127. Zlosnik, J.E., and Speert, D.P. (2010) The role of mucoidy in virulence of bacteria from the Burkholderia cepacia complex: a systematic proteomic and transcriptomic analysis. J Infect Dis 202: 770-781.
128. Zlosnik, J.E., Hird, T.J., Fraenkel, M.C., Moreira, L.M., Henry, D.A., and Speert, D.P. (2008) Differential mucoid exopolysaccharide production by members of the Burkholderia cepacia complex. J Clin Microbiol 46: 1470-1473.
129. Zlosnik, J.E., Costa, P.S., Brant, R., Mori, P.Y., Hird, T.J., Fraenkel, M.C., etal. (2011) Mucoid and nonmucoid Burkholderia cepacia complex bacteria in cystic fibrosis infections. Am J Respir Crit Care Med 183: 67-72.